Results 121 to 130 of about 1,822,600 (198)

FDA-authorized software as a medical device in mental health: a perspective on evidence, device lineage, and regulatory challenges. [PDF]

Npj Ment Health Res
Herpertz J, Stern AD, Opel N, Reininghaus U, Torous J.   +4 more
europepmc   +1 more source

Continuous Glucose Monitoring in Diabetes Care in Saudi Arabia: Addressing Performance Standards and Regulatory Gaps-Literature Review and Consensus Report. [PDF]

J Diabetes Sci Technol
Almehthel M, Alsofiani M, Alzaman N, Alzahrani S, Elbadawi H, Alzubaidi L, Aldawish M, Alotaibi M, Alsabaan F, Aldahash R, Alowairdhi M, Issak ER, Alsifri S.   +12 more
europepmc   +1 more source

Pentaphosphorylated magic spot nucleotides: chemoenzymatic synthesis and disassembly-based sensing.

Org Biomol Chem
Moser P, Roy SK, Herzog M, Bauer F, Wollensack F, Breit B, Jessen HJ.   +6 more
europepmc   +1 more source

Determinants of medication adherence and knowledge among patients with Type 2 diabetes mellitus: A cross-sectional study in Northwestern China. [PDF]

PLoS One
Pan J, Xue X, Li H, Wu L.
europepmc   +1 more source

L'Estel, núm. 510

, 2003
  +4 more sources

Erratum to: Clinical feasibility of the ESCRS IOL power calculator. [PDF]

J Cataract Refract Surg
Pomberger L, Tasch L, Mayer-Xanthaki C, Reifeltshammer SA, Bolz M, Hirnschall N.   +5 more
europepmc   +1 more source

Differences in oral health status between cancer patients: a case-control observational study. [PDF]

BMC Oral Health
Rupe C, Gioco G, Tranfa M, Scilla F, Schiavelli A, Cairo F, Galli J, Scambia G, Rengo C, Lajolo C.   +9 more
europepmc   +1 more source

FDA-Approved AI Solutions in Dental Imaging: A Narrative Review of Applications, Evidence, and Outlook. [PDF]

Int Dent J
Shujaat S, Aljadaan H, Alrashid H, Aboalela AA, Riaz M.   +4 more
europepmc   +1 more source

Molecular evolution and diversity of the norovirus RNA-dependent RNA polymerase. [PDF]

Sci Rep
Flint A, Jawad M, Nasheri N.
europepmc   +1 more source

Molecular screening of natural compounds targeting KRAS(G12C): a multi-parametric strategy against acute lymphoblastic leukemia. [PDF]

J Enzyme Inhib Med Chem
Peng J, Zheng K, Ren L, Cheng J, Feng X, Zhang R.   +5 more
europepmc   +1 more source